Existing Partners

Diurnal has entered into a number of licensing and distribution deals in geographies outside of its core European markets.

Chiesi AustraliaMarketing and distribution agreements for Alkindi and EfmodyAustralia, New Zealand
Consilient HealthMarketing and distribution agreements for Alkindi and EfmodySweden, Norway, Denmark, Finland, Iceland (Efmody only) Netherlands, Belgium, Luxembourg (Alkindi and Efmody)
Eton PharmaceuticalsExclusive licence for AlkindiUnited States, Canada
EffRx Pharmaceuticals SAMarketing and distribution agreements for Alkindi and EfmodySwitzerland, Lichtenstein
Er-KimMarketing and distribution agreements for Alkindi and EfmodyTurkey, Bulgaria, Romania, Greece, Cyprus and Malta
ExCEEd OrphanMarketing and distribution agreements for Alkindi and EfmodyCEE countries including; Albania, Bosnia and Herzegovina, Croatia, Czechia, Hungary, Kosovo, Montenegro, North Macedonia, Poland, Serbia, Slovakia, and Slovenia.
Medomie PharmaMarketing and distribution agreements for Alkindi and EfmodyIsrael, Palestinian Authority
RareStoneExclusive licence for Alkindi and EfmodyChina, Hong Kong,Taiwan and Macau
FrostPharmaMarketing and distribution agreements for AlkindiSweden, Norway, Denmark, Finland, Iceland

| | Vector Pharma | Named patient supply of Alkindi |Middle East and North Africa |

Diurnal Limited (Company Number: 05237326) is registered in England & Wales. Registered office: Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, UK.